Condition

Primary Open-angle Glaucoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 44 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials44

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

44 shown

Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle GlaucomaNCT05264818 · 2022-05-06

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot StudyNCT03921931 · 2018-11-26

Effects of Primary Open-angle Glaucoma on Visual-motor CoordinationNCT06692205 · 2024-11-21

Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle GlaucomaNCT06321562 · 2023-03-01

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and CataractNCT05432245 · 2023-01-18

ENROLLING_BY_INVITATION

GORE Glaucoma Drainage Implant Clinical Study Dominican RepublicNCT05557058 · 2022-09-14

ACTIVE_NOT_RECRUITING

Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle GlaucomaNCT05247762 · 2022-02-28

Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag IsopropylNCT05279716 · 2022-02-15

Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSDNCT04891588 · 2021-03-08

BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular HypertensionNCT03235232 · 2021-02-01

Prevalence of Ocular Surface Disease in Malaysian Glaucoma PatientsNCT04609345 · 2020-11-01

Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)NCT04519814 · 2020-06-30

PRESERFLO® MicroShunt Extension StudyNCT04333433 · 2020-05-22

SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.NCT03931564 · 2020-02-01

Decorin in Sub Scleral TrabeculectomyNCT03924544 · 2019-09-01

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular HypertensionNCT02617459 · 2019-01-04

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351NCT03762369 · 2018-12-07

Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract ExtractionNCT03889652 · 2018-10-20

Impact of Glaucoma and Visual Field Loss on Life SpaceNCT03673644 · 2018-10-09

ACTIVE_NOT_RECRUITING

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)NCT03651336 · 2018-08-15

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle GlaucomaNCT03480711 · 2018-07-10

PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)NCT03193333 · 2017-11-06

Educational Intervention to Adopt SLT as First-Line Glaucoma TreatmentNCT03365778 · 2017-10-23

Post Approval Study of the CyPass SystemNCT03273907 · 2017-10-12

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography StudyNCT03323164 · 2017-07-10

PAIR Study-PAP And IOP Relationship: Study 2NCT03145129 · 2017-03-24

Metabolomics in Surgical Ophthalmological PatientsNCT03098316 · 2017-01-31

Efficacy and Tolerability of an Innovative Formulation of BAK-free LatanoprostNCT03331770 · 2017-01-06

Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation GlaucomaNCT03483402 · 2016-12-01

A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension PatientsNCT03419975 · 2016-04-26

Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.NCT02330978 · 2014-01-01

Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket RegistryNCT01841437 · 2013-09-01

Combined Viscocanalostomy, Phacoemulsification, OIogen Implant in Open Angle GlaucomaNCT03782051 · 2013-08-01

Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle GlaucomaNCT03021629 · 2013-07-01

Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma PatientsNCT03104621 · 2013-03-01

IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway PressureNCT01560975 · 2012-03-01

Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionNCT01528111 · 2012-03-01

Multicentric Observational Study on Quality of Life in GlaucomaNCT01742104 · 2012-03-01

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract SurgeryNCT01461291 · 2012-01-16

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract SurgeryNCT01461278 · 2011-12-22

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma PatientsNCT02077231 · 2011-09-01

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionNCT01410188 · 2011-09-01

Adherence With Fixed Versus Unfixed Glaucoma TherapyNCT01281020 · 2009-05-01

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionNCT00372827 · 2004-02-01

Common interventions

Leading sponsors

Glaukos Corporation3 Alcon Research2 Wills Eye2 Aristotle University Of Thessaloniki1 Cairo University1 Carl Zeiss Meditec AG1 China Medical University Hospital1 Chong Kun Dang Pharmaceutical1 EMS1 EyeD Pharma1 Fondation Ophtalmologique Adolphe de Rothschild1 Gangnam Severance Hospital1 Implandata Ophthalmic Products GmbH1 InnFocus Inc.1 iSTAR Medical1

Trial status mix

COMPLETED28

UNKNOWN8

TERMINATED3

ACTIVE_NOT_RECRUITING2

RECRUITING2

ENROLLING_BY_INVITATION1

Phase mix

NA17

PHASE15

PHASE35

PHASE45

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.